(Z)-hex-3-enyl (Z)-hex-3-enoate

Endpoint summary

Description of key information

Oral: LD50= > 2000 mg/kg bw, male/female rat, OECD 423, RCC Ltd Toxicology Division 2000

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Reference

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

2000

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: Guideline study performed under GLP; minor deviations not considered to affect the integrity of the study.

Qualifier:

according to guideline

Guideline:

OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)

Deviations:

yes

Remarks:

The animals were not fasted overnight prior to dosing

Qualifier:

according to guideline

Guideline:

EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)

Deviations:

yes

Remarks:

The animals were not fasted overnight prior to dosing

GLP compliance:

yes (incl. QA statement)

Remarks:

inspected November 1998; signature: March 1999

Test type:

acute toxic class method

Limit test:

yes

Species:

rat

Strain:

other: Hanlbm: WIST (SPF)

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Recognised animal supplier
- Age at study initiation: 8-10 weeks
- Weight at study initiation: males 237 - 265.5g; females 186.2 - 195.5g
- Fasting period before study: fasted 1 hour before treatment.
- Housing: Groups of three per sex in Makrolon type-4 cages with standard softwood bedding.
- Diet (e.g. ad libitum): certified pelleted diet ad libitum
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: one week

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 - 23.5
- Humidity (%): 40 - 61
- Air changes (per hr): 10 - 15
- Photoperiod: 12 hours light/12 hours dark

IN-LIFE DATES: 15/08/2000 To: 15/09/2000

Route of administration:

oral: gavage

Vehicle:

polyethylene glycol

Details on oral exposure:

VEHICLE
- Concentration in vehicle: 200mg/ml
- Amount of vehicle (if gavage): 10ml/kg
- Justification for choice of vehicle: not reported
- Lot/batch no. (if required): 40537 4/1 30600
- Purity: not reported

MAXIMUM DOSE VOLUME APPLIED: 10ml/kg

Doses:

2000 mg/kg

No. of animals per sex per dose:

3

Control animals:

no

Details on study design:

- Duration of observation period following administration: 15 days
- Frequency of observations and weighing: The animals were examined for clinical signs fourvtimes during test day 1 and once daily during test days 2-15. Mortality/viability was recordedvtogether with clinical signs at the same time intervals on test day 1 and then twice daily on test days 2-15. Body weights were recorded on day 1 prior to administration and on days 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: body weight.

Statistics:

No statistical analysis was used.

Sex:

male/female

Dose descriptor:

LD50

Effect level:

> 2 000 mg/kg bw

Based on:

test mat.

Mortality:

No deaths occurred during the study.

Clinical signs:

other: Slight rales were noted in all female animals on test day 2. Somnolence was observed in all male animals from 2 to 5 hours after the administration and slightly ruffled fur was observed in the same males from 1 to 5 hours (2 males) or from 2 to 5 hours (1

Gross pathology:

No macroscopic findings were observed at necropsy.

Interpretation of results:

not classified

Remarks:

Migrated information Criteria used for interpretation of results: EU

Conclusions:

The acute oral median lethal dose (LD50) of the test material in male and female Hanlbm: WIST (SPF) strain of rat was greater than 2000 mg/kg body weight.

Executive summary:

The study was performed to EU Method B.1 and OECD 423 in accordance with GLP to assess the acute oral toxicity of the test material in the Hanlbm: WIST (SPF) strain of rat. The test material was administered orally, after fasting for 1 hour, once only by gavage. The test material concentration in the vehicle was 200 mg/ml and the administered volume of suspension was 10 ml/kg body weight. 3 male and 3 female test animals were dosed at 2000 mg/kg body weight. Clinical signs and bodyweight development were monitored during the study. All animals were subjected to gross necropsy after an observation period of 15 days. There were no deaths but slight rales were noted in all female animals on test day 2. Somnolence was observed in all male animals from 2 to 5 hours after the administration and slightly ruffled fur was observed in the same males from 1 to 5 hours (2 males) or from 2 to 5 hours (1 male). Hunched posture was observed additionally in one male animal (no.4) from 1 to 5 hours after the administration. Animals showed expected gains in bodyweight during the study. No test-related abnormalities were noted at necropsy. The acute oral median lethal dose (LD50) of the test material in the male and female Hanlbm: WIST (SPF) strain rat was greater than 2000 mg/kg bodyweight.

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed

Dose descriptor:

discriminating dose

Value:

2 000 mg/kg bw

Quality of whole database:

The available information as a whole meets the tonnage driven information requirements of REACH. The substance shows no evidence of acute toxicity by the oral route; no mortality below the limit dose and no significant macroscopic on gross necropsy.

Acute toxicity: via inhalation route

Endpoint conclusion

Endpoint conclusion:

no study available

Acute toxicity: via dermal route

Endpoint conclusion

Endpoint conclusion:

no study available

Additional information

Acute oral:

The study was performed to EU Method B.1 and OECD 423 in accordance with GLP to assess the acute oral toxicity of the test material in the Hanlbm: WIST (SPF) strain of rat. The test material was administered orally, after fasting for 1 hour, once only by gavage. The test material concentration in the vehicle was 200 mg/ml and the administered volume of suspension was 10 ml/kg body weight. 3 male and 3 female test animals were dosed at 2000 mg/kg body weight. Clinical signs and bodyweight development were monitored during the study. All animals were subjected to gross necropsy after an observation period of 15 days. There were no deaths but slight rales were noted in all female animals on test day 2. Somnolence was observed in all male animals from 2 to 5 hours after the administration and slightly ruffled fur was observed in the same males from 1 to 5 hours (2 males) or from 2 to 5 hours (1 male). Hunched posture was observed additionally in one male animal (no.4) from 1 to 5 hours after the administration. Animals showed expected gains in bodyweight during the study. No test-related abnormalities were noted at necropsy. The acute oral median lethal dose (LD50) of the test material in the male and female Hanlbm: WIST (SPF) strain rat was greater than 2000 mg/kg bodyweight.

Justification for selection of acute toxicity – oral endpoint
Only one study available (Klimisch 1)

Justification for classification or non-classification

The substance does not meet classification criteria under EU Directive 67/548/EEC for acute toxicity.

The substance does not meet classification criteria under Regulation (EC) No 1272/2008 for acute toxicity.